Format

Send to

Choose Destination
See comment in PubMed Commons below
Gene Ther. 2005 Jan;12(1):5-11.

siRNA therapeutics: big potential from small RNAs.

Author information

  • 1Department of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.

Abstract

RNA interference (RNAi) is now an umbrella term referring to post-transcriptional gene silencing mediated by either degradation or translation arrest of target RNA. This process is initiated by double-stranded RNA with sequence homology driving specificity. The discovery that 21-23 nucleotide RNA duplexes (small-interfering RNAs, siRNAs) mediate RNAi in mammalian cells opened the door to the therapeutic use of siRNAs. While much work remains to optimize delivery and maintain specificity, the therapeutic advantages of siRNAs for treatment of viral infection, dominant disorders, cancer, and neurological disorders show great promise.

PMID:
15496962
DOI:
10.1038/sj.gt.3302356
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center